rilapladib,
SB-659032,
Rilapladib,
412950-08-4,
UNII-O14CWE893Z,
SB 659032,
SB-659032,
O14CWE893Z,
2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-N-[1-(2-METHOXYETHYL)-PIPERIDIN-4-YL]-4-OXO-N-[[4'-(TRIFLUOROMETHYL)[1,1'-BIPHENYL]-4-YL]METHYL]-1(4H)-QUINOLINEACETAMIDE,
Rilapladib (USAN),
Rilapladib [USAN:INN],
GTPL7376,
SCHEMBL2801812,
CHEMBL2104981,
CTK4I4644,
DTXSID50194281,
ZINC3973276,
BDBM50205805,
AKOS027250919,
DB05119,
PB33181,
AN-28289,
HY-102004,
CS-0022446,
D05728,
Q-4438,
950R084,
1(4H)-Quinolineacetamide, 2-(((2,3-difluorophenyl)methyl)thio)-N-(1-(2-methoxyethyl)-4- piperidinyl)-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)-,
1(4H)-Quinolineacetamide, 2-(((2,3-difluorophenyl)methyl)thio)-N-(1-(2-methoxyethyl)-4-piperidinyl)-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)-,
2-(2-((2,3-Difluorobenzyl)sulfanyl)-4-oxoquinolin-1(4H)-yl)-N-(1-(2-methoxyethyl)piperidin-4-yl)-N-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)acetamide,
2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide,
2-[2-[(2,3-difluorophenyl)methylsulfanyl]-4-oxo-1-quinolyl]-N-[1-(2-methoxyethyl)-4-piperidyl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide,
2-[2-[(2,3-difluorophenyl)methylsulfanyl]-4-oxoquinolin-1-yl]-N-[1-(2-methoxyethyl)piperidin-4-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide,
MTdU,
Rilapladib [USAN],
D05GZD,
D0L0MW,
D0U9YH,
CID9918381,
GSK 659032,
CID 9918381,
194085-75-1,
2-[[ methyl]thio]-N-[1- -4-piperidinyl]-4-oxo-N-[[4'- [1,1'-biphenyl]-4-yl]methyl]-1 -quinolineacetamide,